TABLE A6.
NCI-PRO-CTCAE Score Changes Compared With the Baseline
| Category | Visit | Total (N = 48) | |||||||
|---|---|---|---|---|---|---|---|---|---|
| No. | Mean | SD | Q1 | Median | Q3 | Minimum | Maximum | ||
| Total score | Cycle 3 – cycle 1 | 42 | –5.07 | 13.14 | –8 | –3 | 2 | –43 | 23 |
| Cycle 5 – cycle 1 | 35 | –5.14 | 13.76 | –10 | –1 | 2 | –43 | 15 | |
| Cycle 7 – cycle 1 | 32 | –5.44 | 13.81 | –11 | –2 | 5 | –43 | 13 | |
| Cycle 9 – cycle 1 | 26 | –7.08 | 14.77 | –21 | –2 | 3 | –43 | 13 | |
| Cycle 11 – cycle 1 | 24 | –4.96 | 15.93 | –12 | –0.5 | 5.5 | –40 | 21 | |
| Cycle 13 – cycle 1 | 19 | –4.21 | 16.09 | –10 | 0 | 9 | –43 | 18 | |
| Cycle 15 – cycle 1 | 15 | –6.80 | 17.54 | –24 | 0 | 7 | –43 | 16 | |
| EOT – cycle 1 | 17 | 4.00 | 10.58 | –3 | 5 | 14 | –18 | 21 | |
Abbreviations: EOT, end of treatment: NCI-PRO-CTCAE, National Cancer Institute's Patient Reported Outcome of the Common Terminology Criteria for Adverse Events; Q1, 1st quartile; Q3, 3rd quartile; SD, standard deviation.